| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | -50.2B | -335% |
| Gross Profit | -33.8B | -329% |
| Cost Of Revenue | 3.3B | -49% |
| Operating Income | -6.4B | -223% |
| Operating Expenses | -27.4B | - |
| Net Income | -27.1B | -204% |
| R&D | 4.2B | +23% |
| G&A | 3.3B | -39% |
| Amortization | 1B | -9% |
| Interest Expense | 19MM | -90% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Alphabet Inc. (GOOGL) and Johnson & Johnson (JNJ).
In this article, we discuss 14 best large-cap dividend growth stocks to buy now. You can skip our detailed analysis of large-cap dividend stocks and their historical performance, and go directly to read 5 Best Large Cap Dividend Growth Stocks To Buy Now. Large-cap stocks have remained ideal for investors as they typically form the […]
Johnson & Johnson (JNJ) continued with its long streak of earnings beat but lagged revenue estimates.
Companies In The Article Are:LYV,JNJ,AMD,PNC
Many Johnson & Johnson ( NYSE:JNJ ) insiders ditched their stock over the past year, which may be of interest to the...
Johnson & Johnson (NYSE:JNJ) Q1 2024 Earnings Call Transcript April 16, 2024 Johnson & Johnson isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to Johnson & Johnson’s First Quarter 2024 Earnings Conference Call. All participants will […]
Unveiling JNJ's financial performance, strategic milestones, and future outlook amidst a complex global landscape.
A mixed quarter and narrowed guidance didn't really please investors.
J&J is doubling down on medtech, a typically sleepy sector that has been risky, as it looks to grow after spinning of consumer health segment Kenvue.
UnitedHealth’s adjusted earnings top analysts’ estimates and the stock surges, Trump Media shares extend losses, and quarterly earnings from Bank of America and Morgan Stanley beat expectations.